BMP5 and prostate carcinoma: Our obtained results revealed that BMP5 expression was down-regulated in bladder, breast, colorectal, gastric, kidney, lung, ovarian, prostate cancer and sarcoma compared to the expression level in normal cases (Figure 1A) whereas up-regulation was only found to be in the central nervous system (CNS) cancer.